GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

KIMS acquires 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 Crore

M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 29 Oct 2026, 10:59 PM IST  ·  BSE ID: f57c0de8-b274-41ee-882e-539e12c5763b
View Original BSE Filing (PDF)
💡
In Simple Terms
KIMS bought a 5.82% share in a Sangli hospital, Ushahkal Abhinav Specialty Hospital LLP, for ₹15 Crore.
🤖 AI Summary
  • KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 Crore.
  • The acquisition was made via cash consideration through primary infusion.
  • Ushahkal Abhinav Specialty Hospital LLP reported a Turnover of ₹80.42 Crore for FY26.
  • The target entity, founded in 2022, is a 316-bed quaternary care facility in Sangli, Maharashtra.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Stake Acquired
5.82%
Cost of Acquisition
₹15 Crore
Ushahkal Abhinav Specialty Hospital LLP FY26 Turnover
₹80.42 Crore
9.34
Ushahkal Abhinav Specialty Hospital LLP FY26 PAT
-₹23.59 Crore
Ushahkal Abhinav Specialty Hospital LLP FY26 Networth
₹116.42 Crore
Ushahkal Abhinav Specialty Hospital LLP FY25 Turnover
₹73.55 Crore
13.90
Ushahkal Abhinav Specialty Hospital LLP FY24 Turnover
₹64.51 Crore
🏢 How This Affects the Company
📈
Business Impact
This acquisition represents a strategic investment in the healthcare industry, expanding KIMS's presence through a stake in a 316-bed quaternary care facility with potential for expansion to over 500 beds.
💰
Financial Impact
The acquisition involved a cash outflow of ₹15 Crore for KIMS. The target entity, Ushahkal Abhinav Specialty Hospital LLP, reported a Networth of ₹116.42 Crore for FY26.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this acquisition intimation.
👤
Who Is Affected
Existing shareholders of KIMS are affected by the company's deployment of ₹15 Crore cash for a strategic minority investment in Ushahkal Abhinav Specialty Hospital LLP.
🔍
Management Signal
This decision indicates management's intent to pursue strategic investments within the healthcare sector to expand its portfolio and reach.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
KIMS's upcoming quarterly financial results for Q3 FY27 to assess cash position.
Future disclosures regarding the operational performance of Ushahkal Abhinav Specialty Hospital LLP.
Any further investments or stake changes in Ushahkal Abhinav Specialty Hospital LLP by KIMS.
MEDIUM RISK Investment in a minority stake of an entity reporting losses carries execution and profitability risks.
💡 Investor Takeaway
Krishna Institute of Medical Sciences Ltd has acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for ₹15 Crore. The target hospital, founded in 2022, reported a Turnover of ₹80.42 Crore and a Networth of ₹116.42 Crore for FY26, with a PAT of -₹23.59 Crore.
⚖️ Strengths & Concerns

✅ Positives

  • Strategic investment in Ushahkal Abhinav Specialty Hospital LLP, a quaternary care facility with current capacity of 316 beds and expansion potential.
  • The target entity, Ushahkal Abhinav Specialty Hospital LLP, showed a turnover growth from ₹64.51 Crore in FY24 to ₹80.42 Crore in FY26.

⚠️ Concerns

  • Ushahkal Abhinav Specialty Hospital LLP reported a PAT of -₹23.59 Crore for FY26, indicating a loss in the latest fiscal year.
  • The acquisition gives KIMS a minority stake of 5.82%, limiting direct control over the target entity's operations.
❓ Frequently Asked Questions
What stake did Krishna Institute of Medical Sciences Ltd acquire in Ushahkal Abhinav Specialty Hospital LLP?
Krishna Institute of Medical Sciences Ltd acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP.
What was the consideration for KIMS's acquisition of Ushahkal Abhinav Specialty Hospital LLP stake?
The consideration for the acquisition was ₹15 Crore, paid in cash by way of primary infusion.
What was the turnover of Ushahkal Abhinav Specialty Hospital LLP in FY26?
Ushahkal Abhinav Specialty Hospital LLP reported a Turnover of ₹80.42 Crore for FY26.
What was the Profit After Tax (PAT) of Ushahkal Abhinav Specialty Hospital LLP in FY26?
Ushahkal Abhinav Specialty Hospital LLP reported a PAT of -₹23.59 Crore for FY26.
What is the bed capacity of Ushahkal Abhinav Specialty Hospital LLP?
Ushahkal Abhinav Specialty Hospital LLP has a current capacity of 316 beds with potential for expansion to over 500 beds.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.